Canopy Growth Corporation

Marijuana activists in Arizona started the “Smart & Safe Arizona Initiative” as a ballot measure for 2020. The group gathered enough signatures.

As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

The FDA doesn’t allow CBD products to be used as a food derivative. The agency has been hesitant about how some cannabis companies market CBD products.

On Tuesday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it will temporarily close all of its company-owned Tokyo Smoke and Tweed retail stores.

Hexo (TSE:HEXO) has been struggling for a while now. The string of bad news started in October 2019 when CFO Michael Monahan resigned.

The Tennessee Senate passed a medical marijuana bill due to the rising benefits of medical marijuana. However, the bill includes a poison pill.

Aurora Cannabis (NYSE:ACB) stock has fallen below $1 on the NYSE, which puts it at the risk of being delisted from the exchange.

The marijuana legalization process in US states is speeding up in 2020. Many new states are coming up with their own proposals to legalize marijuana.

Recently, the House proposed a bill to legalize recreational cannabis. However, marijuana legalization hopes have crashed in New Mexico for this year.

Due to rising financial constraints, US cannabis companies are seeking bankruptcy protection from Canada. In the US, marijuana still isn’t legal at the federal level.

Marijuana legalization is getting a lot of support in the US in 2020. Legalizing marijuana has kicked many drug cartels out of the market.

President Trump introduced a proposal to end an existing policy introduced by Congress. The proposal will be part of the fiscal 2021 budget plan.

Canopy Growth will report its earnings for the third quarter of fiscal 2020 before the market opens on Friday. Analysts expect the revenue to rise.

Tulsi Gabbard has been a big supporter of marijuana legalization. Recently, she spoke about how she wants all illicit drugs to be legal and not just marijuana.

Most US states are looking forward to cannabis legalization in 2020. Recently, Governor Andrew Cuomo promised to legalize cannabis in New York in 2020.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Constellation Brands (STZ) is scheduled to release its earnings results for the third quarter of fiscal 2020 on January 8.

Aphria impressed analysts and cannabis investors in 2019. While the cannabis sector’s struggles pulled down Aphria stock, the company did well overall.

Aurora Cannabis (ACB) has had a tough year. The stock is down 63.1% in 2019. Let’s see how analysts have lowered their expectations for it in recent months.

Donald Trump has never openly supported marijuana legalization, and this month, Trump has shared some conflicting views on medical marijuana legalization.

Canopy Growth has focused on its acquisition strategy since Canada legalized cannabis in 2018, expanding its medical cannabis market in Europe and globally.

Warren Buffett is one of the greatest value investors in the world. He’s invested in companies across various sectors, but he’s avoided cannabis. Why?

The Dow Jones Index needs a Santa Claus rally this year. Instead, the Dow Jones might have to contend with the “Tariff Man.”

Aurora Cannabis (ACB) (ACB.TO) is a Canadian cannabis giant, but the company’s plans to enter the US market keep getting delayed.

Aurora Cannabis’s Q1 cash cost of production fell to 0.85 Canadian dollars. Aurora credited its Sky facility’s cost-efficient cannabis cultivation.

Recreational marijuana is now legal in Michigan. It took the step in 2018, but the licensing process and regulations took awhile.

We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.

Jim Cramer expressed disappointment with the cannabis industry, claiming it may not be the “incredible opportunity” he thought it was.

In today’s Get Real, we took a closer look at Uber’s trouble and an unexpected boost for Canopy Growth while markets react to more unrest.

Aurora Cannabis reported its third-quarter results after the market closed on November 14. Despite some positives, it fell 18% on November 15.

Cowen & Co. increased its estimates for the US cannabis market, expecting $85 billion in sales by 2030. Its previous sales forecast was $80 billion.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.

Leading cannabis producer Canopy Growth reported disappointing fiscal 2020 second-quarter earnings results on November 14.

Twitter is dealing with a scandal and Airbus seems to be making the most of the Boeing crisis. Plus, Canopy Growth has a new partner.

Legal cannabis in Mexico is going through several twists and turns. The country first allowed medical marijuana in June 2017.

Canopy Growth (CGC) is set to release its fiscal 2020 second-quarter earnings results on November 14. Let’s take a look at the word on Wall Street.

On October 30, Wisconsin lawmakers introduced a bill to decriminalize marijuana possession. Here are five things to know about Wisconsin and legalization.

Media reports indicate that Angela Merkel’s party may consider legalizing cannabis in Germany. Medical marijuana has been legal in Germany since 2017.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

Aurora Cannabis (ACB) strengthened its footing in the medical cannabis industry by launching a new product. The stock rose 2.1% in pre-market trading today.

As of October 4, Aurora Cannabis was trading at a forward EV-to-EBITDA multiple of 33.05x compared to 68.8x at the beginning of September.

Canopy Growth (WEED) (CGC) stock has been under pressure since it reported its earnings for the first quarter of fiscal 2020 on August 14.

Cannabis regulation in Mexico is a key topic this week. The US, Canadian, and Mexican economies are more closely intertwined than other countries.

Aurora Cannabis posted its fourth-quarter earnings after the market closed on Wednesday. The company posted revenues of 98.9 million Canadian dollars.

Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.

Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.

HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.